Nestle Health Science (NHS) China, a subsidiary of Nestle, the global food and beverage giant, has joined with the Chinese Maternal and Child Health Association, Yao.Tamll, Babytree, Kidswant and other cross-industry professional leading platforms to establish the "Anti-Allergy Alliance" in a bid to promote food allergy prevention and management in the country.

The alliance aims to build a professional modern "anti-allergy" ecosystem and to boost the healthy growth of babies and children with food allergies in the country.

Cecily Gu, regional business head of Nestlé Health Science Greater China, said: "Children's health is related to the harmony and happiness of hundreds of millions of families, and it is imperative to master the scientific management of food allergies in infants and young children."

Allergic diseases are listed by the World Health Organization as one of the key preventive diseases in the 21st century.

The number of infants and toddlers with food allergies in China has also been on the rise in recent years.

NHS China announced a full pipeline of food allergy management products, including food for special medical purposes. Its series for infants has received Chinese registration licenses, including extensively hydrolyzed formulas Althéra and Alfaré, and amino acid formula Alfamino.

NHS China said its supplementary food for infants and toddlers, Spoonfulone, has been officially launched in the China market through cross-border e-commerce and is developed by leading food allergy experts from Stanford University and supported by clinical research. Nestle said the Spoonfulone products contain 16 food proteins responsible for over 90 percent of food allergies.